Riad Sherif
Algemeen Directeur bij OCULIS HOLDING AG
Vermogen: 10 M $ op 30-04-2024
Actieve functies van Riad Sherif
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
REVENIO GROUP OYJ | Directeur/Bestuurslid | 08-04-2022 | - |
Independent Dir/Board Member | 08-04-2022 | - | |
OCULIS HOLDING AG | Directeur/Bestuurslid | 01-12-2017 | - |
Algemeen Directeur | 01-12-2017 | - | |
Investor Relations Contact | 01-12-2017 | - | |
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Directeur/Bestuurslid | - | - |
Algemeen Directeur | 01-01-2017 | - | |
XPND Medical SA | Voorzitter | 01-01-2016 | - |
Oprichter | 01-01-2016 | - |
Loopbaan van Riad Sherif
Eerdere bekende functies van Riad Sherif
Bedrijven | Functie | Begin | Einde |
---|---|---|---|
EURO BIOT | Directeur/Bestuurslid | 28-02-2023 | - |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Corporate Officer/Principal | - | - |
Sanofi-Aventis Algérie SpA | Corporate Officer/Principal | - | - |
Alcon Finland OY | Corporate Officer/Principal | - | - |
Statistieken
Internationaal
Zwitserland | 5 |
Finland | 3 |
Verenigde Staten | 2 |
Operationeel
Director/Board Member | 4 |
Corporate Officer/Principal | 3 |
Chief Executive Officer | 2 |
Sectoraal
Health Technology | 4 |
Commercial Services | 2 |
Finance | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
Beursgenoteerde bedrijven | 2 |
---|---|
REVENIO GROUP OYJ | Health Technology |
OCULIS HOLDING AG | Health Technology |
Bedrijven in privébezit | 6 |
---|---|
Oculis SA
Oculis SA Miscellaneous Commercial ServicesCommercial Services Oculis SA focuses on ophthalmic drugs and novel drug delivery to the eye. The Oculis drug delivery platform consists of a novel technique to facilitate drug absorption to both anterior and posterior parts of the eye. The advantage is a drug delivery system where diseases of the posterior part of the eye can be treated with a simple topical application. The Oculis drug delivery platform allows diseases such as DME (diabetic macular edema) at the posterior part of the eye to be treated with a non-invasive topical application. The company was founded by Einar Stefansson and Thorsteinn Loftsson in 2003is headquartered in Pully, Switzerland. | Commercial Services |
Alcon Finland OY | |
Novartis Corp.
Novartis Corp. Pharmaceuticals: MajorHealth Technology Novartis Corp. manufactures pharmaceuticals, vaccines, consumer health, generics, eye care and animal health products. It manufactures drugs for oncology, hypertension, diabetes, cancer and cardiovascular diseases. The company was founded on November 15, 1996 and is headquartered in New York, NY. | Health Technology |
Sanofi-Aventis Algérie SpA | |
European Biotech Acquisition Corp.
European Biotech Acquisition Corp. Financial ConglomeratesFinance European Biotech Acquisition Corp. is a blank check company which was formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination. The company was founded on January 8, 2021 and is headquartered in Lausanne, Switzerland. | Finance |
XPND Medical SA |
- Beurs
- Insiders
- Riad Sherif
- Ervaring